Note 4 - Inventories
|12 Months Ended|
Jun. 30, 2016
|Notes to Financial Statements|
|Inventory Disclosure [Text Block]||
Note 4. Inventories:
Inventories consist of (in thousands):
At June 30, 2016 and 2015, the Company had $23.4 million and $24.0 million, respectively, of excess protein, antibody and chemically-based inventory on hand which was not valued.
The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.
Reference 1: http://www.xbrl.org/2003/role/presentationRef